Impact of Long-term Treatment With Continuous Tenofovir Alafenamide or After Switching From Tenofovir Disoproxil Fumarate on Hepatocellular Carcinoma Incidence in Patients With Chronic Hepatitis B

Conference Reports for NATAP

AASLD
The Liver Meeting
November Fri, Nov 10, 2023 - Mon, Nov 14, 2023


Impact of Long-term Treatment With Continuous Tenofovir Alafenamide or After Switching From Tenofovir Disoproxil Fumarate on Hepatocellular Carcinoma Incidence in Patients With Chronic Hepatitis B

	AASLD nov 10-14 https://www.aasld.org/the-liver-meeting